To inform continued development of the novel immune agent GEN-1, we compared ovarian cancer patients' end points from a neoadjuvant single-arm phase IB study with those of similar historic clinical ...
The emerging role of pharmacists in optimizing therapeutic substitutions within the US Oncology network. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback